March 31, 2016 by Chain Drug Review
Brian Cornell, Chain Drug Review, Charles Redfield, Jeff Jones, Jody Pinson, John Standley, Judy Sansone, mass market retailers, Racher Press, Retailer of the Year awards, Rick Dreiling, slideshow, Stefano Pessina
Featured Articles, Slideshows
NEW YORK — Racher Press Inc., the publisher of Chain Drug Review and Mass Market Retailers, presented its 2015 Retailer of the Year awards last evening in New York City. The annual event drew retailer and supplier executives from across the food, drug and mass channel to a ballroom at the new headquarters of Time
February 22, 2016 by Geoff Walden and Chain Drug Review
Rite Aid, Stefano Pessina, Walgreens Boots Alliance
2016, Issue 02-22-2016, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. stockholders voted overwhelmingly this month to approve the company’s $17.2 billion acquisition by Walgreens Boots Alliance Inc. (WBA). Some 97% of the votes cast at a special meeting of stockholders were in favor of the deal. A quorum of 72% of Rite Aid’s total outstanding shares of common
February 8, 2016 by Chain Drug Review
Rite Aid, Stefano Pessina, Valeant Pharmaceuticals, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2016, Issue 02-08-2016, Issues, News
NEW YORK — Stefano Pessina likes what he sees after Walgreens Boots Alliance (WBA) finished its first full year as a unified company. WBA’s executive vice chairman and chief executive officer told shareholders at its annual meeting here that the company expects its deal to acquire Rite Aid Corp. and its partnership with Valeant Pharmaceuticals
February 4, 2016 by Geoff Walden and Chain Drug Review
CVS Health, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. stockholders have voted overwhelmingly to approve the company’s $17.2 billion deal to be acquired by Walgreens Boots Alliance Inc. Approximately 97% of the votes cast at a special meeting of stockholders on Thursday were in favor of the deal. A quorum of 72% of Rite Aid’s total outstanding
January 27, 2016 by Chain Drug Review
Alliance Boots, James Skinner, Rite Aid, Stefano Pessina, Valeant Pharmaceuticals, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — Walgreens Boots Alliance’s deal to acquire Rite Aid and partnership with Valeant Pharmaceuticals will build on WBA’s strong start in its first full year as a unified company, executive vice chairman and CEO Stefano Pessina said here at the annual shareholders meeting. “I am happy to say that we are on track
January 7, 2016 by Chain Drug Review
Alliance Boots, Duane Reade, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) topped Wall Street’s earnings projections for its fiscal 2016 first quarter. WBA said Thursday that for the first quarter ended Nov. 30, 2015, adjusted net earnings attributable to Walgreens Boots Alliance were $1.13 billion, or $1.03 per diluted share, compared with $749 million, or 78 cents per diluted
January 4, 2016 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, Stefano Pessina, Walgreens, Walgreens Boots Alliance
Uncategorized
DEERFIELD, Ill. — When asked what motivates him, Stefano Pessina, the driving force behind the creation of Walgreens Boots Alliance (WBA), says simply, “I like to build things.” The understated elegance of the response typifies the man, but it underplays the magnitude of his achievement. A savvy dealmaker, Pessina, who has a degree in nuclear
January 4, 2016 by Chain Drug Review
Chain Drug Review, John Standley, Retailer of the Year, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
2016, Business, Featured Articles, Issue 01-04-2016, Issues, Leading Headlines, News, Retail News
For 2015, the editors of Chain Drug Review have chosen to give the publication’s annual Retailer of the Year honors to two chain drug retail industry leaders: Stefano Pessina, executive vice chairman and CEO of Walgreens Boots Alliance Inc., and the management team at Rite Aid Corp., led by chairman and CEO John Standley. Pessina’s
January 4, 2016 by Geoff Walden and Chain Drug Review
Federal Trade Commission, John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
2016, Issue 01-04-2016, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. stockholders will vote next month on the company’s merger with Walgreens Boots Alliance (WBA). Rite Aid has scheduled a February 4 special stockholders meeting for the balloting. Stockholders as of the close of business on December 18 will be eligible to vote. Rite Aid and WBA also announced
January 4, 2016 by David Pinto and Chain Drug Review
chain drug retailing, David Pinto, George Riedl, Helena Foulkes, John Standley, mass retailing, Stefano Pessina
2016, Issue 01-04-2016, Issues, Opinion
Christmas is over, yesterday’s news. And the mass retailing community is scampering to assess its impact on sales, earnings and the future. For chain drug retailers, this holiday selling season, like so many before it, was acceptable, if hardly record-setting. As in previous years, America’s drug chains suffered from an absence of exciting new products
November 9, 2015 by Geoff Walden and Chain Drug Review
Adam Fein, Alex Gourlay, chain drug retailing, CVS/pharmacy, Drug Channels Institute, George Fairweather, John Standley, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2015, Issue 11-09-2015, Issues, News
DEERFIELD, Ill. — The consolidation of chain drug retailing climaxed last month with Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. In the largest outright purchase of a chain in the industry’s history, WBA agreed to acquire Rite Aid for $9 per share, or $17.2 billion, including debt. The price represents a premium
November 9, 2015 by Geoff Walden and Chain Drug Review
Alex Gourlay, Alliance Boots, AmerisourceBergen, Linda Filler, Richard Ashworth, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2015, Business, Issue 11-09-2015, Issues, News
DEERFIELD, Ill. — The acquisition of Rite Aid Corp. culminates sweeping change at Walgreens in the space of a little over three years. In linking its fortunes, starting in June 2012, to Alliance Boots GmbH and its dynamic leader, Stefano Pessina, the chain adopted a global outlook focusing simultaneously on scale and efficiency. Its merger
November 9, 2015 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2015, Issue 11-09-2015, Issues, Leading Headlines, Opinion
Stefano Pessina is once again changing the face of community pharmacy. Three years after Alliance Boots, the global retail and distribution powerhouse he created, entered into a partnership with Walgreens, and less than a year after the two companies finalized their merger, Pessina has struck another deal that will reverberate throughout the U.S. health care
October 28, 2015 by Chain Drug Review
Alex Gourlay, George Fairweather, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
CDR Blog
The morning after announcing its $17.2 billion agreement to acquire Rite Aid, Walgreens Boots Alliance (WBA) didn’t have much to say about the deal. In a conference call on WBA’s fiscal 2015 results, company executives cited the synergies of scale and broader U.S. market coverage that the addition of Rite Aid promises, but details weren’t